Loading...
Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Wesley Y Naritoku, MD, PhD

    TitleProfessor of Clinical Pathology
    SchoolKeck School of Medicine of USC
    DepartmentPathology
    AddressCT 1200 North State Street
    Off Campus
    Los Angeles California 90033
    Phone+1 323 409 6689
    vCardDownload vCard
      Other Positions
      TitleDirector of Residency Program At LAC+USC Medical Center


      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Wei CH, Pettersson J, Campan M, Chopra S, Naritoku W, Martin SE, Ward PM. Gain of TP53 Mutation in Imatinib-treated SDH-Deficient Gastrointestinal Stromal Tumor and Clinical Utilization of Targeted Next-generation Sequencing Panel for Therapeutic Decision Support. Appl Immunohistochem Mol Morphol. 2016 Dec 23. PMID: 28027118.
        View in: PubMed
      2. Naritoku W, Powell SZ, Black-Schaffer WS. Evolution of the Pathology Residency Curriculum: Preparing for a Positive Future. Acad Pathol. 2016 Jan-Dec; 3:2374289516667746. PMID: 28725779.
        View in: PubMed
      3. Naritoku W, Timmons CF. The Pathologist Pipeline: Implications of Changes for Programs and Post-Sophomore Fellowships-Program Directors' Section Perspective. Acad Pathol. 2016 Jan-Dec; 3:2374289516646117. PMID: 28725767.
        View in: PubMed
      4. McGoey R, Naritoku W, Furlong MA. Identifying the Challenges of "Small" Pathology Residency Programs and Creating Collaborative Solutions. Acad Pathol. 2016 Jan-Dec; 3:2374289516643541. PMID: 28725764.
        View in: PubMed
      5. Jensen TW, Ray T, Wang J, Li X, Naritoku W, Han B, Bellafiore F, Bagaria SP, Qu A, Cui X, Taylor CR, Ray PS. Diagnosis of Basal-Like Breast Cancer Using a FOXC1-Based Assay. J Natl Cancer Inst. 2015 Aug; 107(8). PMID: 26041837; PMCID: PMC4554196.
      6. Naritoku W, Black-Schaffer WS. Cytopathology fellowship milestones. Cancer Cytopathol. 2014 Dec; 122(12):859-65. PMID: 25236620.
        View in: PubMed
      7. Iezzoni JC, Ewton A, Chévez-Barrios P, Moore S, Thorsen LM, Naritoku W. Selective pathology fellowships: diverse, innovative, and valuable subspecialty training. Arch Pathol Lab Med. 2014 Apr; 138(4):518-25. PMID: 24678683.
        View in: PubMed
      8. Naritoku W, Alexander CB. Pathology milestones. J Grad Med Educ. 2014 Mar; 6(1 Suppl 1):180-1. PMID: 24701281; PMCID: PMC3966611.
      9. Naritoku W, Alexander CB, Bennett BD, Black-Schaffer WS, Brissette MD, Grimes MM, Hoffman RD, Hunt JL, Iezzoni JC, Johnson R, Kozel J, Mendoza RM, Post MD, Powell SZ, Procop GW, Steinberg JJ, Thorsen LM, Nestler SP. The pathology milestones and the next accreditation system. Arch Pathol Lab Med. 2014 Mar; 138(3):307-15. PMID: 24576024.
        View in: PubMed
      10. Naritoku W, Vasovic L, Steinberg JJ, Prystowsky MB, Powell SZ. Anatomic and clinical pathology boot camps: filling pathology-specific gaps in undergraduate medical education. Arch Pathol Lab Med. 2014 Mar; 138(3):316-21. PMID: 24576025.
        View in: PubMed
      11. Chaiwun B, Sukhamwang N, Trakultivakorn H, Saha B, Young L, Tsao-Wei D, Naritoku W, Groshen S, Taylor CR, Imam SA. GSTPi-positive tumour microenvironment-associated fibroblasts are significantly associated with GSTPi-negative cancer cells in paired cases of primary invasive breast cancer and axillary lymph node metastases. Br J Cancer. 2011 Oct 11; 105(8):1224-9. PMID: 21897388; PMCID: PMC3208492.
      12. Guo J, Young SK, Lorenzo CR, Lee CM, Kanel GC, Brynes RK, Chandrasoma P, Naritoku W. Phlegmonous gastritis in a patient with myeloid sarcoma: a case report. Appl Immunohistochem Mol Morphol. 2009 Oct; 17(5):458-62. PMID: 19644358.
        View in: PubMed
      13. Saha B, Kaur P, Tsao-Wei D, Naritoku W, Groshen S, Datar RH, Jones LW, Imam SA. Unmethylated E-cadherin gene expression is significantly associated with metastatic human prostate cancer cells in bone. Prostate. 2008 Nov 01; 68(15):1681-8. PMID: 18712716.
        View in: PubMed
      14. Saha B, Arase A, Imam SS, Tsao-Wei D, Naritoku W, Groshen S, Jones LW, Imam SA. Overexpression of E-cadherin and beta-catenin proteins in metastatic prostate cancer cells in bone. Prostate. 2008 Jan 01; 68(1):78-84. PMID: 18008331.
        View in: PubMed
      15. Saha B, Chaiwun B, Imam SS, Tsao-Wei DD, Groshen S, Naritoku W, Imam SA. Overexpression of E-cadherin protein in metastatic breast cancer cells in bone. Anticancer Res. 2007 Nov-Dec; 27(6B):3903-8. PMID: 18225549.
        View in: PubMed
      16. Saha B, Chaiwun B, Tsao-Wei DD, Groshen SL, Naritoku W, Atkinson RD, Taylor CR, Imam SA. Telomerase and markers of cellular proliferation are associated with the progression of cervical intraepithelial neoplasia lesions. Int J Gynecol Pathol. 2007 Jul; 26(3):214-22. PMID: 17581401.
        View in: PubMed
      17. Horowitz RE, Naritoku W. The autopsy as a performance measure and teaching tool. Hum Pathol. 2007 May; 38(5):688-695. PMID: 17376512.
        View in: PubMed
      18. Laine LA, Nathwani RA, Naritoku W. The effect of GI bleeding on Helicobacter pylori diagnostic testing: a prospective study at the time of bleeding and 1 month later. Gastrointest Endosc. 2005 Dec; 62(6):853-9. PMID: 16301025.
        View in: PubMed
      19. Saha B, Zhang N, Naritoku W, Tsao-Wei DD, Groshen SL, Carlsson G, Larsson L, Gustavsson B, Chaiwun B, Taylor CR, Imam SA. LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer. Anticancer Res. 2004 Jul-Aug; 24(4):2391-400. PMID: 15330189.
        View in: PubMed
      20. Horowitz RE, Naritoku W, Wagar EA. Management training for pathology residents: a regional approach. Arch Pathol Lab Med. 2004 Jan; 128(1):59-63. PMID: 14692810.
        View in: PubMed
      21. Baltayan A, Naritoku W, Chaiwun B, Tsao-Wei DD, Groshen S, Hern RA, Gusterson BA, Taylor CR, Imam SA. LEA.135 expression: identifies low-risk patients with breast ductal carcinoma in situ. Anticancer Res. 2002 Sep-Oct; 22(5):2933-7. PMID: 12530020.
        View in: PubMed
      22. Formenti SC, Spicer D, Skinner K, Cohen D, Groshen S, Bettini A, Naritoku W, Press M, Salonga D, Tsao-Wei D, Danenberg K, Danenberg P. Low HER2/neu gene expression is associated with pathological response to concurrent paclitaxel and radiation therapy in locally advanced breast cancer. Int J Radiat Oncol Biol Phys. 2002 Feb 01; 52(2):397-405. PMID: 11872285.
        View in: PubMed
      23. Liu D, Naritoku W, Tsao-Wei D, Groshen S, Neville MA, Taylor CR, Cote RJ, Imam SA. LEA.135 expression: an independent and favorable prognostic biomarker for patients with primary invasive breast cancer. Int J Cancer. 2000 May 20; 89(3):224-9. PMID: 10861497.
        View in: PubMed
      24. Liu D, Baltayan A, Naritoku W, Barr NJ, Young LL, Chaiwun B, Tsao-Wei DD, Groshen SL, Taylor CR, Torloni H, Neville AM, Cote RJ, Imam SA. LEA.135 expression: its comparison with other prognostic biomarkers for patients with primary breast carcinoma. Anticancer Res. 2000 May-Jun; 20(3A):1451-61. PMID: 10928056.
        View in: PubMed
      25. Datar RH, Naritoku W, Li P, Tsao-Wei D, Groshen S, Taylor CR, Imam SA. Analysis of telomerase activity in ovarian cystadenomas, low-malignant-potential tumors, and invasive carcinomas. Gynecol Oncol. 1999 Sep; 74(3):338-45. PMID: 10479490.
        View in: PubMed
      26. Naritoku W, Datar RH, Li P, Groshen SL, Taylor CR, Imam SA. Telomerase activity: comparison between fine-needle aspiration and biopsy specimens for the detection of tumor cells. Cancer. 1999 Aug 25; 87(4):210-5. PMID: 10455209.
        View in: PubMed
      27. Cohen H, Rose S, Lewin DN, Retama B, Naritoku W, Johnson C, Bautista L, Crowe H, Pronovost A. Accuracy of four commercially available serologic tests, including two office-based tests and a commercially available 13C urea breath test, for diagnosis of Helicobacter pylori. Helicobacter. 1999 Mar; 4(1):49-53. PMID: 10352087.
        View in: PubMed
      28. Bennett DR, Baird CJ, Chan KM, Crookes PF, Bremner CG, Gottlieb MM, Naritoku W. Zinc toxicity following massive coin ingestion. Am J Forensic Med Pathol. 1997 Jun; 18(2):148-53. PMID: 9185931.
        View in: PubMed
      29. Laine L, Lewin DN, Naritoku W, Cohen H. Prospective comparison of H&E, Giemsa, and Genta stains for the diagnosis of Helicobacter pylori. Gastrointest Endosc. 1997 Jun; 45(6):463-7. PMID: 9199901.
        View in: PubMed
      30. Laine L, Lewin D, Naritoku W, Estrada R, Cohen H. Prospective comparison of commercially available rapid urease tests for the diagnosis of Helicobacter pylori. Gastrointest Endosc. 1996 Nov; 44(5):523-6. PMID: 8934155.
        View in: PubMed
      31. Yang R, Naritoku W, Laine L. Prospective, randomized comparison of disposable and reusable biopsy forceps in gastrointestinal endoscopy. Gastrointest Endosc. 1994 Nov-Dec; 40(6):671-4. PMID: 7859962.
        View in: PubMed
      32. Krasne DL, Naritoku W, Cosgrove MM. Diagnosis of syncytial (lacunar cell-predominant) nodular sclerosing Hodgkin's disease by fine needle aspiration. A case report. Acta Cytol. 1993 May-Jun; 37(3):418-22. PMID: 7684549.
        View in: PubMed
      33. Naritoku W, Taylor CR. Immunohistologic diagnosis of 2 cases of metastatic prostate cancer to breast. J Urol. 1983 Aug; 130(2):365-7. PMID: 6192256.
        View in: PubMed
      34. Naritoku W, Taylor CR. A comparative study of the use of monoclonal antibodies using three different immunohistochemical methods: an evaluation of monoclonal and polyclonal antibodies against human prostatic acid phosphatase. J Histochem Cytochem. 1982 Mar; 30(3):253-60. PMID: 7037942.
        View in: PubMed